Wednesday, May 23, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Iroko Pharmaceuticals Engages SynopiaRx to Navigate Managed Care Landscape
MarketWatch (press release)
CARY, NC, May 23, 2012 (BUSINESS WIRE) -- SynopiaRx today announced that it has partnered with Iroko Pharmaceuticals, LLC to manage the company's access plan for its investigational nonsteroidal anti-inflammatory drugs (NSAIDs) currently in late-stage ...
See all stories on this topic »
Tonix Pharmaceuticals CEO Interviewed on CEOLive.TV
MarketWatch (press release)
NEW YORK, May 23, 2012 (BUSINESS WIRE) -- Tonix Pharmaceuticals Holding Corp. (OBB:TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), ...
See all stories on this topic »
APP Pharmaceuticals Acquires Three Products from Nexus
MarketWatch (press release)
SCHAUMBURG, Ill., May 23, 2012 (BUSINESS WIRE) -- APP Pharmaceuticals, LLC, a Fresenius Kabi Company, today announced it has acquired three products from Nexus Pharmaceuticals, Inc. Under terms of the agreement APP takes complete ownership of the ...
See all stories on this topic »
Veloxis Pharmaceuticals announces a restructuring of the company to support ...
MarketWatch (press release)
HORSHOLM, Denmark, May 23, 2012 /PRNewswire via COMTEX/ -- Veloxis Pharmaceuticals A/S (omx:VELO) today announced that it contemplates restructuring the company's operations in order to fully focus its resources on the completion of the development and ...
See all stories on this topic »
PPD Names David Simmons Chairman and CEO
MarketWatch (press release)
WILMINGTON, NC, May 23, 2012 (BUSINESS WIRE) -- Pharmaceutical Product Development, LLC (PPD) today announced that its board of directors has named David Simmons chairman and CEO. Mr. Simmons, an experienced pharmaceutical industry executive, ...
See all stories on this topic »
Mylan Launches Generic Version of Viramune® Tablets
MarketWatch (press release)
PITTSBURGH, May 23, 2012 /PRNewswire via COMTEX/ -- Mylan Inc. (NASDAQ:MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug ...
See all stories on this topic »
Bayer, Onyx cancer drug fails in late-stage study
BusinessWeek
By AP A cancer treatment from Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals Inc. failed to meet its main, late-stage study goal of improving overall survival in patients with advanced cases of lung cancer. The companies said Tuesday they ...
See all stories on this topic »
Vietnam Stocks: Vietcombank, VietinBank, OPC Pharmaceutical
Bloomberg
OPC Pharmaceutical Joint-Stock Co. (OPC) , a manufacturer and trader of herbal medicines, fell 1.5 percent to 33200 dong, heading for the lowest close since April 4. SSI Vision Fund cut its stake in the company to 8 percent from 10 percent, ...
See all stories on this topic »
Has Momenta Pharmaceuticals Become the Perfect Stock?
msnbc.com
Let's discuss the ideal qualities of a perfect stock, then decide if Momenta Pharmaceuticals fits the bill. The quest for perfection Stocks that look great based on one factor may prove horrible elsewhere, making due diligence a crucial part of your ...
See all stories on this topic »
FURIEX PHARMACEUTICALS, INC. : Furiex Confirms Takeda's Announcement on the ...
4-traders
Furiex Pharmaceuticals, Inc. : Furiex Confirms Takeda's Announcement on the Acceptance of the European Medicines Agency Submission of Alogliptin for the Treatment of Type 2 Diabetes Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today confirmed that ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost